Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
aducanumab
advances in neurology
adverse drug reaction
algorithm
Alzheimer's disease
Alzheimer's disease, early onset
Alzheimer's disease, pathogenesis
Alzheimer's disease, treatment of
amyloid
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, inflammatory type
amyloid beta protein
amyloid beta protein antibodies
amyloid beta-related angiitis
amyloid deposition
amyloid plaques
amyloid-related imaging abnormalities
aneurysm
aneurysm, intracranial
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
anti-amyloid therapy
anticoagulant, reversal of
anticoagulant, treatment
apolipoprotein E
apoliprotein E, plasma level
B 12 deficiency
Behcet's syndrome
biologic markers
blood pressure
brain biopsy
carbon monoxide poisoning
CAT scan
CAT scan, emission
CAT scan, emission, abnormal
central nervous system, infection of
central pontine myelinolysis
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebral venous thrombosis
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident, complications with
cerebrovascular disease
chemotherapy, CNS treatment and complications with
coma
complications
confusion
contraindications
controversies in neurology
cortical blindness
cost
coumarin
dementia
dementia, rapidly progressive
dementia, reversible
dementia, treatment of
demyelinating disease
disease modifying agents
dizziness
donanemab
efficacy
emergency room
emergency room, treatment of stroke
encephalitis, human immunodeficiency virus type 1
encephalitis, viral
enzyme inhibition
gadolinium
gantenerumab
Glasgow coma score
gliomatosis cerebri
granulomatous disease
headache
hearing loss
hemosiderosis of CNS, superficial
hemosiderosis, subarachnoid
human immunodeficiency virus type 1
hypertension
hypertensive encephalopathy
iatrogenic neurologic disorders
immunomodulation
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, pathophysiology
intracerebral hemorrhage, small
intracranial pressure, increased
intracranial pressure, increased, treatment of
lecanemab
leukoencephalopathy
leukoencephalopathy, differential diagnosis
limbic encephalitis
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
meningeal biopsy
meningeal enhancement
mental status, abnormal
microhemorrhage, intracerebral
migraine
mild cognitive impairment
misdiagnosis
mitochondrial disease
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, mass effect on
multiple sclerosis
myoclonus
negative
neoplasm, primary of CNS
neurologic examination, focal
neuropathology
phenylketonuria
Pittsburgh Compound B
platelet inhibiting drugs
pleocytosis of cerebrospinal fluid
posterior leukoencephalopathy syndrome
prevention of neurologic disorders
prognosis
progressive multifocal leucoencephalopathy
radiation therapy, CNS treatment and complications with
recombinant activated factor VII
remternetug
reversible neurologic disorder
review article
risk factors
safety
sarcoidosis
sarcoidosis, CNS
seizure
shared decision making
symmetric brain lesions
temporal lobe
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
transient neurologic deficit
treatment of neurologic disorder
vasculitides
vasculopathy
Whipple's disease
white matter disease
Showing articles 300 to 350 of 11262 << Previous Next >>

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

N-methyl-D-aspartate Receptor Autoimmune Encephalitis Presenting With Opsoclonus-Myoclonus
Arch Neurol 68:1069-1072, Smith, J.H.,et al, 2011

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies in a Child A Treatable Condition?
Arch Neurol 68:1065-1068, Korff, C.M.,et al, 2011

Analysis of Relapses in Anti-NMDAR Encephalitis
Neurol 77:996-999, Gabilondo, I.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
Arch Neurol 68:1156-1164, Clifford, D.B.,et al, 2011

Autoimmune Limbic Encephalitis with GAD Antibodies
The Neurohospitalist 1:178-181, Finelli, P.F., 2011

Paraneoplastic and Autoimmune Encephalitis
UpToDate, June, Dalmau, J.,et al, 2011

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

Treat Alzheimer Disease Before It Is Symptomatic
Arch Neurol 68:1237-1238, , 2011

Longitudinal Change of Biomakers in Cognitive Decline
Arch Neurol 68:1257-1266,1237, Lo, R.Y.,et al, 2011

Autoimmune Encephalopathy
Semin Neurol 31:144-157, Flanagan, E.,et al, 2011

Hashimotos Encephalopathy
Radiol Case Reports 6:445-449, Ramalho, J. & Castillo, M., 2011

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Predictors of Neurologic Outcome in Hypothermia After Cardiac Arrest
Ann Neurol 68:907-914, Fugate,J.E.,et al, 2010

Safety and Efficacy of Natalizumab in Children With Multiple Sclerosis
Neurol 75:912-917, Ghezzi,A.,et al, 2010

Cerebral Amyloid Angiopathy
UpToDate: May 2010, Greenberg,S.M.,et al, 2010

An Effective Immunotherapy Regimen for VGKC Antibody-Positive Limbic Encephalitis
JNNP 81:1167-1169, Wong,S.H.,et al, 2010

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Aspirin and Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy
Neurol 75:693-698, Biffi,A.,et al, 2010

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010

Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis
Neurol 74:521-523, Gutwinski,S.,et al, 2010

Reversible Paraneoplpastic Limbic Encephalitis Associated with Antibodies to the AMPA Receptor
Neurol 74:265-267, Bataller,L.,et al, 2010

Long-Term Survival with Favorable Cognitive Outcome After Chemotherapy in Primary Central Nervous System Lymphoma
Ann Neurol 67:182-189, Juergens,A.,et al, 2010

Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010

Antibodies to Glutamic Acid Decarboxylase Define a Form of Limbic Encephalitis
Ann Neurol 67:470-478, Malter,M.P., et al, 2010

Response to Immunotherapy in a 20-Month-Old Boy With Anti-NMDA Receptor Encephalitis
Neurol 74:1550-1551, Wong-Kisiel,L.C., et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Treatment of Refractory Neurosarcoidosis with Infliximab
JNNP 81:241-246, Santos,E., et al, 2010

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

A Case of Neurosarcoidosis Successfully Treated with Rituximab
Neurol 75:568-570, Bomprezzi,R., et al, 2010

Open Biopsy in Patients With Acute Progressive Neurologic Decline and Absence of Mass Lesion
Neurol 75:419-424, Schuette,A.J., et al, 2010

Clinicopath Conf, Inflamatory Cerebral Amyloid Angiopathy,
NEJM 363:373-381, Case 22-2010, 2010

Clinical Reasoning: A 9-year-old Girl With Seizures and Encephalopathy
Neurol 74:e97-e100, Nguyen,T.P. &El-Hakam,L.M., 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Acute Toxoplasmosis Infection in a Patient with Ankylosing Spondylitis Treated with Adalimumab: A Case Report
Reumatismo 62:283-285, Azevedo V.F., et al, 2010

Periarteritis Nodosa
www.MedLink.com, June, Ramachandran, T. & Roos, R., 2010

Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009

Acute Limbic Encephalitis and Glutamic Acid Decarboxylase Antibodies:A Reality?
J Neurosci 287:69-71, Blanc,F.,et al, 2009

Limbic Encephalitis Associated with Anti-GAD Antibody and Common Variable Immune Deficiency
Dev Med Child Neurol 51:563-567, Akman,C.I.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Diagnosis and New Treatment in Muscle Channelopathies
JNNP 80:360-365, Meola,G.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009



Showing articles 300 to 350 of 11262 << Previous Next >>